Panel Discussion | Finding the Suitable Patient for TEER

Saturday, March 7, 2026

2:40 PM - 3:08 PM EST

Location: Jefferson

Moderator(s)

Anita W. Asgar, MD, FACC, FSCAI

Interventional Cardiologist
Northwestern Medicine
Chicago, Illinois, United States

Disclosure(s): Abbott Cardiovascular Systems: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Anteris: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic Cardiovascular: Consulting Fees (e.g., advisory boards) (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing); W.L. Gore & Associates: Consulting Fees (e.g., advisory boards) (Ongoing)
Michael J. Rinaldi, MD

Director Structural Heart Program
Sanger Heart and Vascular Institute/Atrium Health
Charlotte, North Carolina, United States

Disclosure(s): PiCardia: Consulting Fees (e.g., advisory boards) (Ongoing)

Panel Discussant(s)

Chirag Bavishi, MD, MPH

Director, Structural Heart Program
University of Missouri at Columbia

Disclosure(s): No financial relationships to disclose
Colin Barker, Sr., MD

Director
VUMC
Nashville, Tennessee, United States

Disclosure(s): No financial relationships to disclose
Anthony DeMaria, MD

Judy and Jack White Chair in Cardiology
University of California, San Diego
La Jolla, California, United States

Disclosure(s): Medtronic, Novartis, OrbusNeich, Penumbra, PhaseBio, Philips, Pi-Cardia, PLx Pharma, Protembis, RenalPro, RM Global, Shockwave, Vivasure, Zoll: Grant/Research Support (Ongoing)
Rani K. Hasan, MD, MHS

Assistant Professor of Medicine
Johns Hopkins University, Maryland, United States

Disclosure(s): SSVP HRT LLC: Stock-privately held company (Ongoing)
Christian Hengstenberg, MD

Head of Department
Medical University of Vienna
Vienna, Austria

Disclosure(s): Abbott Cardiovascular Systems: Grant/Research Support (Ongoing); Boston Scietific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards Lifesciences LLC: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Disclosure(s):

Anita W. Asgar, MD, FACC, FSCAI: Abbott Cardiovascular Systems: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Anteris: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic Cardiovascular: Consulting Fees (e.g., advisory boards) (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing); W.L. Gore & Associates: Consulting Fees (e.g., advisory boards) (Ongoing)

Michael J. Rinaldi, MD: PiCardia: Consulting Fees (e.g., advisory boards) (Ongoing)

Chirag Bavishi, MD, MPH: No financial relationships to disclose

Colin Barker, MD, Sr.: No financial relationships to disclose

Anthony DeMaria, MD: Medtronic, Novartis, OrbusNeich, Penumbra, PhaseBio, Philips, Pi-Cardia, PLx Pharma, Protembis, RenalPro, RM Global, Shockwave, Vivasure, Zoll: Grant/Research Support (Ongoing)

Rani K. Hasan, MD, MHS: SSVP HRT LLC: Stock-privately held company (Ongoing)

Christian Hengstenberg, MD: Abbott Cardiovascular Systems: Grant/Research Support (Ongoing); Boston Scietific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards Lifesciences LLC: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)